| 7:00am | Check-in and Breakfast in Exhibit Hall |
| 8:00am | Horizon CME App Overview |
| 8:10am | Welcome, Introductions, & CE Housekeeping |
| Block One: TBA |
| 8:15am | (01) TBA » TBA |
| 9:15am | Break – Refreshments in the Exhibit Hall |
| Block Two: Foundations of Oncology Clinical Trials |
|
| 9:40am | (02) Clinical Trials from Soup to Nuts » TBA |
| 10:05am | (03) Foundations of Oncology Clinical Trial Design » Erin Pierce, MSN, APRN, FNP-C – Associate Clinical Investigator | Nurse Practitioner | HonorHealth Research Institute | Scottsdale, AZ |
| 10:30am | (04) Evaluating the Quality of a Clinical Trial » Erin Pierce, MSN, APRN, FNP-C – Associate Clinical Investigator | Nurse Practitioner | HonorHealth Research Institute | Scottsdale, AZ |
| 10:50am | (05) Q+A Panel and Discussion: Block Two » Faculty from Sessions 02-04 |
| 11:00am | Gather for Lunch |
| 11:10am | Non-CME Symposium Lunch Sponsored by TBA » TBA |
| 11:55am | Dessert – Refreshments in Exhibit Hall |
| Block Three: Panel Discussion: The Clinical Research Team in Practice |
| 12:10pm | (06) Panel Discussion: The Clinical Research Team in Practice » TBA |
| 12:40pm | (07) APP Perspectives of Targeting KRAS » Erin Pierce, MSN, APRN, FNP-C – Associate Clinical Investigator | Nurse Practitioner | HonorHealth Research Institute | Scottsdale, AZ |
| 1:10pm | Message from the Cancer Charities |
| 1:25pm | Break – Trivia for Charity in the Exhibit Hall |
| Block Four: Participating in Clinical Trials: Practical Skills for APPs |
| 1:45pm | (09) APP Responsibilities as a Sub-Investigator in Clinical Trials » Gayle Jameson, MSN, ACNP-BC, AOCN – Nurse Practitioner | Clinical Research Consultant | Associate Clinical Investigator |
| 2:15pm | (10) Grading and Documenting Adverse Events in Clinical Trials: “Side Effects May Include…” » Madeline Merrill, AGNP-BC, MSN – Clinical Trials Nurse Practitioner | Memorial Sloan Kettering Cancer Center | New York, NY |
| 2:45pm | (11) Building Investigator Excellence » Bridget O’Brien, DNP, APRN, FNP-BC, AOCNP – Associate Professor, Director of FNP Program | Rush University | Oncology Nurse Practitioner | Northwestern Medicine | Chicago, IL | Chair of the ECOG-ACRIN APP Committee |
| 3:15pm | (12) Q+A Panel and Discussion: Block Four » Faculty from Sessions 09 – 11 |
| 3:25pm | Break – Refreshments in the Exhibit Hall |
| Block Five: Expanding Access to Clinical Trials in Underserved Populations |
| 3:50pm | (13) Patient Journey and Involvement in Clinical Trials » Kelly Shanahan, MD – President and Director of Research, METAvivor | Member, Patient Centered Dosing Initiative |
| 4:15pm | (14) Improving Diversity and Representation in Oncology Clinical Trials » Diane Barber, PhD, ANP-BC, AOCNP, FAANP, FAAN – Manager of Advanced Practice Providers | Department of Investigational Cancer Therapeutics | MD Anderson | Houston, TX |
| 4:40pm | (15) Expanding Clinical Trial Access in Rural Communities » Christa Braun-Inglis, DNP, APRN-Rx, FNP-BC, AOCNP – Nurse Practitioner/Assistant Researcher/CCDR Lead | University of Hawaii Cancer Center/Hawaii M/U NCORP | Clinical Faculty, UH Nancy Atmospera-Walch School of Nursing | Honolulu, HI |
| 5:00pm | (16) Q+A Panel and Discussion: Block Five » Faculty from Sessions 13-15 |
| 5:10pm | Networking Reception – Exhibit Hall |
| 7:00am | Check-in |
| 7:55am | Horizon CME App Overview and CE Housekeeping |
| 8:00am | Welcome and Introductions |
| Block Six: Leading Clinical Research: Designing and Conducting Your Own Studies |
| 8:05am | (17) Where to Begin: From Being a Sub-investigator to Clinical Trial Leadership » Gayle Jameson, MSN, ACNP-BC, AOCN – Nurse Practitioner | Clinical Research Consultant | Associate Clinical Investigator |
| 8:30am | Gather for Breakfast |
| 8:35am | Non-CME Breakfast Symposium Sponsored By TBA » TBA |
| 9:20am | Transition Break |
| 9:25am | (18) APP Involvement in Clinical Trial Design: Developing a Research Question and Protocol » Ke Yang, RN, BSN, MSN, DNP, PhD, AGNP, AOCNP – Nurse Practitioner, Precision Genomics Program | Hematology, Oncology | IU Health Simon Cancer Center | Indiana University Health | Indianapolis, Indiana |
| 9:50am | (19) Collaborating with a Biostatistician to Develop Your Own Oncology Clinical Trial » Bill Brady, PhD – Principal Biostatistician | Development Innovations | Sarah Cannon Research Institute | Nashville, TN |
| 10:15am | (20) From Numbers to Narrative: Mastering the Art of Interpreting and Presenting Clinical Research Data » Carol Peyton Bryant, DNP, RN, ACNP-BC – NP & PA Supervisor, Oncology & Hematology | Mayo Clinic | Phoenix, AZ |
| 10:35am | (21) Q+A Panel and Discussion: Block Six » Faculty from Sessions 17 – 20 |
| 10:45am | Break – Refreshments in the Exhibit Hall + Poster Session |
| Block 7: Clinical Trial Methodology (Shared Session With STOP Cancer) |
| 11:50am | (22) Bringing Trials to Patients » TBA |
| 12:10pm | (23) Novel Endpoints for Therapeutic Response in Early Phase Trials » TBA |
| 12:30pm | (24) Statistical Trial Design for Early Phase Clinical Trials » TBA |
| 12:50pm | (25) Role of Advocacy in Drug Development » TBA |
| 1:10pm | (26) Q+A Panel and Discussion: Block Seven » Faculty from Sessions 22-25 |
| 1:30pm | Gather for Lunch |
| 1:35pm | Buffet Lunch / Non-CME/CE Presentation Sponsored by TBA » TBA |
| 2:20pm | Dessert Break in the Exhibit Hall |
| Block Eight: Bringing Bispecific Antibody and CAR T-cell Therapy into the Community Setting |
| 2:35pm | (27) Lymphoma: Update on Bispecific Antibody Therapy and CAR T-cell Therapy and Ongoing Clinical Trials » Laura J. Zitella, MS, RN, ACNP-BC, AOCN – Associate Clinical Professor, Hematology Nurse Practitioner | University of California, San Francisco | San Francisco, CA |
| 3:15pm | Break – Refreshments in the Exhibit Hall |
| 3:35pm | (28) Solid Tumors: Update on Bispecific Antibody Therapy and Ongoing Clinical Trials » Laura J. Zitella, MS, RN, ACNP-BC, AOCN – Associate Clinical Professor, Hematology Nurse Practitioner | University of California, San Francisco | San Francisco, CA |
| 4:00pm | (29) Clinical Trial Experience: Operationalizing Bispecific Antibody Therapy in the Community Setting » TBA |
| 4:30pm | (30) Q+A Panel and Discussion: Block Eight » Faculty from Sessions 27-29 |
| 4:35pm | Closing Comments |